Cargando…
CYP24A1 depletion facilitates the antitumor effect of vitamin D3 on thyroid cancer cells
It has been demonstrated that 25-hydroxyvitamin-D3-24-hydroxylase (CYP24A1) is a key enzyme that neutralizes vitamin D activity, which may have an anti-tumor effect. Therefore, the aim of the current study was to explore the effect of the active metabolite of vitamin D, 1,25-dihydroxyvitamin D (1,25...
Autores principales: | Hu, Ning, Zhang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143870/ https://www.ncbi.nlm.nih.gov/pubmed/30233662 http://dx.doi.org/10.3892/etm.2018.6536 |
Ejemplares similares
-
Synthesis and CYP24A1-Dependent Metabolism of 23-Fluorinated
Vitamin D(3) Analogues
por: Kawagoe, Fumihiro, et al.
Publicado: (2019) -
Expression of vitamin D receptor, CYP24A1, and CYP27B1 in normal and inflamed canine pancreases
por: Lee, Dohee, et al.
Publicado: (2023) -
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis()
por: Ramasamy, Adaikalavan, et al.
Publicado: (2014) -
24-Hydroxylase Deficiency Due to CYP24A1 Sequence Variants: Comparison With Other Vitamin D−mediated Hypercalcemia Disorders
por: Azer, Sarah M, et al.
Publicado: (2021) -
Epigenetic regulation of the 1,25-dihydroxyvitamin D(3) 24-hydroxylase (CYP24A1) in colon cancer cells
por: Höbaus, Julia, et al.
Publicado: (2013)